Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
NCT ID: NCT00049751
Last Updated: 2006-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
3000 participants
INTERVENTIONAL
2002-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adalimumab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must also have DAS of 3.2 or greater at study entry,
* normal laboratory parameters and ESR \>20,
* satisfactory response or intolerance to one or more prior DMARDs and
* be willing and able to give informed consent.
Exclusion:
* Previous treatment with total lymphoid irradiation or anti-CD4 or CAMPATH 1H monoclonal antibodies resulting in persistent CD4 lymphopenia,
* history of acute inflammatory joint disease other than RA,
* prior treatment with cyclophosphamide or chlorambucil,
* prior treatment with intravenous immunoglobulin within 70 days,
* history of malignant lymphoma,
* history of uncontrolled diabetes,
* unstable ischemic heart disease,
* active inflammatory bowel disease,
* active peptic ulcer disease or stroke,
* positive HIV status,
* positive serology for Hepatitis B or C,
* no previous history of tuberculosis or listeria infection,
* no previous history of cancer other than successfully treated skin cancer;
* women can not be pregnant or be breastfeeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William M. Edwards, M.D.
Role: PRINCIPAL_INVESTIGATOR
Low Country Research Center, North Charelston SC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thomas McGee, MD
Mobile, Alabama, United States
Desert Valley Medical
Apple Valley, California, United States
Kenneth Hsu, MD, Inc.
Bakersfield, California, United States
Rheumatology Clinic
Los Angeles, California, United States
Michael Harrington, MD
Napa, California, United States
Midori Jane Nishio, MD
Walnut Creek, California, United States
Naveen Raja, MD
Whittier, California, United States
Mountain Rheumatology
Denver, Colorado, United States
Division of Rheumatic Diseases/University of CT Health Center
Farmington, Connecticut, United States
New Haven Medical Group, PC
New Haven, Connecticut, United States
Norman Gaylis, MD
Aventura, Florida, United States
Mike Schweitz, MD
West Palm Beach, Florida, United States
Maurice McCarthy, MD
Winter Haven, Florida, United States
Intermountain Orthopedics
Boise, Idaho, United States
Institute of Arthritis Research
Idaho Falls, Idaho, United States
Loyola University Medical Center
Maywood, Illinois, United States
West Suburban Health Care
Oak Park, Illinois, United States
OSF Medical Group -Rheumatology
Peoria, Illinois, United States
Rockford Clinic, Clinical Research Department
Rockton, Illinois, United States
Pain Therapy Center
Schaumburg, Illinois, United States
Baton Rouge Clinic
Baton Rouge, Louisiana, United States
Thomas Pressly, MD
Shreveport, Louisiana, United States
Rheumatology Associates
Portland, Maine, United States
Northampton Internal Medicine Association
Northampton, Massachusetts, United States
Fallon Clinic Research
West Boylston, Massachusetts, United States
John Howland, MD
Bay City, Michigan, United States
Freeman Health Systems
Joplin, Missouri, United States
Peggy Schlesinger, MD
Missoula, Montana, United States
NJ Associates in Medicine
Fair Lawn, New Jersey, United States
Internal Medicine and Rheumatic Diseases
Millburn, New Jersey, United States
Placido Morano, MD
Brooklyn, New York, United States
NYU Hospital for Joint Disease
New York, New York, United States
Alan Kaell, MD
Port Jefferson Station, New York, United States
Carolina Bone and Joint, PA
Monroe, North Carolina, United States
Gordon Senter, MD Rheumatology, PA
Salisbury, North Carolina, United States
MedCenter One Health Systems
Bismarck, North Dakota, United States
University Hospital of Cleveland
Beachwood, Ohio, United States
Arthritis Clinic
Canton, Ohio, United States
STAT Research, Inc.
Dayton, Ohio, United States
Arthritis and Osteoporosis Clinic, LLC
Bend, Oregon, United States
Jel M. Depper, MD
Bend, Oregon, United States
Sanford and Roumm Rheumatology
Camp Hill, Pennsylvania, United States
Frederick Murphy, MD
Duncansville, Pennsylvania, United States
Rheumatology Associates
Norristown, Pennsylvania, United States
Rheumatology Associates, Ltd.
Sellersville, Pennsylvania, United States
Low Country Research Center
North Charleston, South Carolina, United States
Medical Specialists of Nashville
Nashville, Tennessee, United States
Arthritis and Osteoporosis Clinical Research Center of Central Texas
Waco, Texas, United States
Center of Arthritis and Rheumatic Disease, PC
Chesapeake, Virginia, United States
Margaret Gradzka, MD
Fairfax, Virginia, United States
Metropolitan Clinical Research
Falls Church, Virginia, United States
Northern Virginia Center for Arthritis
Reston, Virginia, United States
Lewis-Gale Clinic
Salem, Virginia, United States
ROAD Clinic
Lakewood, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Burmester GR, Landewe R, Genovese MC, Friedman AW, Pfeifer ND, Varothai NA, Lacerda AP. Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis. Ann Rheum Dis. 2017 Feb;76(2):414-417. doi: 10.1136/annrheumdis-2016-209322. Epub 2016 Jun 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M02-498
Identifier Type: -
Identifier Source: org_study_id